| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bioage Labs, Inc. (BIOA) has 10 insiders with recent SEC Form 4 filings, including 11 buys and 8 sells. BIOA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 976.9K | $17.48M | - | |
| Other | 45.0K | $805.3K | - | |
| CFO | 25.9K | $464.4K | - | |
| Dir | 22.0K | $393.7K | - | |
| Dir | 22.0K | $393.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2026 | Goldstein Dov A Md | Chief Financial Officer | Sale+OE | 27,000 | $19.70 | $531,827.69 | -18.0% | -21.7% | - | |
| Jan 13, 2026 | Fortney Kristen | Chief Executive Officer | Sell | 233,107 | $18.12 | $4,223,036.34 | -19.3% | -21.7% | - | |
| Jan 2, 2026 | Rubin Paul D | Chief Medical Officer | Sale+OE | 7,433 | $12.85 | $95,490.26 | -100% | +36.4% | - | |
| Dec 9, 2025 | Rubin Paul D | Chief Medical Officer | Sale+OE | 18,000 | $12.00 | $216,000.00 | -100% | +63.5% | - | |
| Dec 4, 2025 | Rubin Paul D | Chief Medical Officer | Sale+OE | 68,897 | $10.19 | $701,908.86 | -100% | +100.7% | - | |
| Oct 3, 2024 | Pande Vijay Satyanand | Director | Buy | 219,195 | $19.75 | $4,329,019.37 | +7.3% | -73.3% | -73.1% | |
| Sep 27, 2024 | Barton Shane | Principal Accounting Officer | Buy | 2,632 | $18.00 | $47,376.00 | New | -72.0% | -74.2% | |
| Sep 27, 2024 | Cormorant Asset Management, LP50 | - | Buy | 450,000 | $18.00 | $8,100,000.00 | +38.2% | -72.0% | -74.2% | |
| Sep 27, 2024 | Pande Vijay Satyanand | Director | Buy | 900,000 | $18.00 | $16,200,000.00 | New | -72.0% | -74.2% | |
| Sep 27, 2024 | Healy James | Director | Buy | 666,665 | $18.00 | $11,999,970.00 | +40.7% | -72.0% | -74.2% |